Analyst
Long Equity Partners
Equibles does not estimate personal net worth.
Rupesh Tatia is recorded as Analyst at Long Equity Partners. Rupesh Tatia has spoken on 3 earnings calls across 3 companies, most recently for Orchid Pharma Limited on August 21, 2026. Those appearances were for Orchid Pharma Limited, Supriya Lifescience Limited and Yasho Industries Limited. The companies whose calls Rupesh Tatia spoke on are classified in the Healthcare and Basic Materials sectors.
“First question is, some data you gave on vials. I don't know if it was for inventors or back terms. Could you please just repeat that?”
“My first question is, sir, on this cardiovascular intermediate. I mean, you are saying that you have order book which will, you know, utilize, let's say, 300 metric ton of capacity.”
“Can you tell me what percentage of your revenue comes from automotive engine oils and what percentage comes from industrial engine oils? And with the EV penetration, what kind of risk do you see to our portfolio?”
Long Equity Partners
Analyst
Transcript header (unverified)
Orchid Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Supriya Lifescience Limited
Biotechnology · Healthcare
Yasho Industries Limited
Specialty Chemicals · Basic Materials
Earnings Call for the Quarter Ended June 30, 2026
Orchid Pharma Limited
Supriya Lifescience Limited Q4 FY26 Earnings Conference Call
Supriya Lifescience Limited
Earnings Call
Yasho Industries Limited
